Respiratory Diseases Drugs Global Market Report 2018

Starting Price : $ 4000.00 | Pages : 125 | Published : February 2018 | SKU CODE : 3261 | Format :

Respiratory Diseases Drugs market covers drugs that are used in the treatment of a wide range of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), chronic and acute bronchitis, emphysema and cystic fibrosis. Some of the major drugs in the market include antimuscarinics, corticosteroids, codral®, coldrex® and lemsip®.

Respiratory Diseases Drugs Global Market Size

North America was the largest region in the respiratory diseases drugs market in 2017, accounting for 48% market share. This was mainly due to high number of patients with respiratory diseases, more people covered under medical insurance programs and higher pricing of medications in the USA. Asia Pacific was the second largest region accounting for 19% market share. Africa was the smallest region accounting for 2% market share. This is attributed to the small size of population in the region.

Respiratory Diseases Drugs Global Market Trend

The demand for PSE-containing cold, allergy, and sinus products is growing due to their effectiveness and convenience. PSE is an active ingredient found in various cold, allergy, and sinus drugs that can provide congestion relief. However, PSE-containing medicines are mostly sold as a prescription drug, as PSE can also be used for the illegal manufacture of methamphetamine, a recreational drug. This has led drug manufacturers to produce tamper-resistant PSE products. For instance, in March 2017, pharmaceutical companies Acura Pharmaceuticals Inc. and MainPointe Pharmaceuticals LLC entered into an agreement, enabling MainPointe Pharmaceuticals LLC to market NEXAFED and NEXAFED Sinus products in the US and Canada. These drugs utilize tamper-resistant PSE formulation to prevent the illicit production of methamphetamine.

The companies covered are GlaxosmithKline Plc, AstraZeneca Plc, Merck & Co, Novartis AG, and Johnson & Johnson.

The countries covered are USA, China, Germany, Brazil, Japan, UK, Spain, Russia, France, Australia, Italy, India and rest of the world.

Respiratory Diseases Drugs Global Market Segmentation

The respiratory diseases drugs market is segmented into Anti-Asthmatics And COPD Drugs; and Cough And Cold Preparations.

Anti-Asthmatics And COPD Drug companies produce drugs that can be used to relieve the frequency of acute attacks of asthma, emphysema, chronic bronchitis, and nocturnal awakenings.

Cough And Cold Preparations Drug companies produce drugs containing active ingredients such as acetaminophen, antihistamines, dextromethorphan, decongestants, and ethanol that can be used to treat cough and cold.

Automation In Air Purification Manufacturing Sector
Wearable Technologies To Shorten The Distance Between Doctor And Patient
Next-gen Biologics- The Way Forward
The Telemedicine Technology Market Will More Than Double by 2022
Minor Orthopedic Replacement Implants Global Market Exceeds $1.5 Billion
Minor orthopedic implant market to be worth $2.2 billion by 2021, analysts say
Organs-on-Chips to Revolutionize the Drug Development Industry
Russia’s Musculoskeletal Drugs Market Is Catching Up With The Rest Of Europe
Blood Glucose Test Strips Global Market Report 2018
View Report
Veterinary Services Global Market Report 2018
View Report
Podiatry Services Global Market Strategies and Opportunities to 2021
View Report
Minor Orthopedic Implants Replacement Global Market Opportunities And Strategies To 2021
View Report
Biologics Global Market Opportunities And Strategies To 2021
View Report
Pharmaceutical Drugs Global Market Opportunities And Strategies To 2021
View Report
Blood Glucose Test Strips Global Market Opportunities And Strategies To 2021
View Report
Veterinary Services Global Market Opportunities And Strategies To 2021
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)